Multiple sclerosis relapse following gamma knife radiosurgery for meningioma in a patient treated with natalizumab: case report.

Authors

Maryna Turbinska, Nabeela Nathoo, Penelope Smyth

Published in

Frontiers in oncology. Volume 16. Pages 1959731. Epub Oct 09, 2026.

Abstract

We describe a case of a patient with multiple sclerosis (MS) stable on natalizumab who developed widespread gadolinium-enhancing lesions and clinical relapse seven and eight months after gamma knife radiosurgery (GKRS) for left cerebellar convexity meningioma. We explore how increased blood-brain barrier (BBB) permeability post-GKRS could potentially interfere with the lymphocyte anti-trafficking effect of natalizumab and result in new central nervous system (CNS) inflammation distant from the radiation site.
Comprehensive analysis of the patient's chart, brain and spine imaging, serum and cerebrospinal fluid (CSF) profiles was conducted. We compiled a graphical representation of treatment changes, radiologic findings, and GKRS initiation within one timeframe. We conducted a structured literature review to support the discussion of this case and hypothesize possible pathophysiological mechanisms contributing to clinical and radiological findings.
Seven months after GKRS, follow-up brain magnetic resonance imaging (MRI) demonstrated multiple gadolinium-enhancing lesions in both cerebral hemispheres, and repeat imaging one month later revealed new gadolinium-enhancing lesions, correlating with the patient's clinical relapse. Alternative causes of disease progression, including radiation-induced demyelination, radionecrosis, opportunistic infections, progressive multifocal leukoencephalopathy (PML), and development of anti-natalizumab antibodies, were explored and considered less likely. The patient was switched to ofatumumab with subsequent clinical and radiological stability.
Given extensive new inflammatory lesions far from the GKRS site, it seems unlikely that the sole mechanism was radiation-induced neurotoxicity. We hypothesize that late delayed radiation side effects caused by GKRS may have enabled peripheral lymphocytes to enter the CNS, counteracting the effects of natalizumab on blocking lymphocyte trafficking through the BBB and possibly contributing to MS relapse.

PMID:
42920560
Bibliographic data and abstract were imported from PubMed on 24 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.